about
Molecular characterization of Streptococcus agalactiae isolates harboring small erm(T)-carrying plasmids.Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.Non-O1/Non-O139 Vibrio cholerae Avian Isolate from France Cocarrying the bla(VIM-1) and bla(VIM-4) Genes.Chronic endocarditis due to Legionella anisa: a first case difficult to diagnose.High Prevalence of SXT/R391-Related Integrative and Conjugative Elements Carrying blaCMY-2 in Proteus mirabilis Isolates from Gulls in the South of FrancePartition locus-based classification of selected plasmids in Klebsiella pneumoniae, Escherichia coli and Salmonella enterica spp.: an additional tool.Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.Central venous catheters and biofilms: where do we stand in 2017?Successful treatment of Pseudomonas aeruginosa osteomyelitis with antibiotic monotherapy of limited duration.Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus.Primary osteomyelitis caused by an NDM-1-producing K. pneumoniae strain of the highly virulent sequence type 23.Complete nucleotide sequence of two multidrug-resistant IncR plasmids from Klebsiella pneumoniae.Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis.Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniaeAnswer to January 2017 Photo Quiz.Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.Assessment of Carbapenem Resistance in Enterobacteriaceae with the Rapid and Easy-to-Use Chromogenic β Carba Test.Carbapenemase-producing bacteria in patients hospitalized abroad, FranceFirst Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso.Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia.Targeting relaxase genes for classification of the predominant plasmids in Enterobacteriaceae.In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections.Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.β LACTA test for rapid detection of Enterobacteriaceae resistant to third-generation cephalosporins from positive blood cultures using briefly incubated solid medium cultures.Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase.Persistence of blaCMY-2-producing Proteus mirabilis in two gull colonies at a 1-year interval in Southern France.Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC.In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium sppMolecular characterization of DHA-1–producing Klebsiella pneumoniae isolates collected during a 4-year period in an intensive care unit
P50
Q34596454-C7899636-ABC9-4C9C-9EE8-FC2803A95E55Q35960711-077EE2EA-78B1-4E0A-B043-848C8F8813FBQ36075834-C1DBE045-A446-4A4D-8D90-7C04ECAAA076Q36297442-A8520824-E500-4948-87F8-DD66A41F3283Q36571845-22A80067-D6B3-4B8F-AC3D-AEB1A3B1F071Q38301442-B043AE65-5588-4816-8991-5241F1C01747Q38744413-611E45B3-6DC6-4D73-AD15-5B88767B15B1Q39240750-DA2E7E30-F01C-413D-9DFC-114BAA0BF349Q40150820-79B553B2-A54D-4921-BDFC-A3F0F70326D6Q40368667-53A9537E-D640-40C5-939F-932FBC1C0332Q41079553-8818B4A0-16BE-4825-953E-8AF90620889DQ41080556-35F75355-443E-4B41-97CF-9A5BE56C3DC0Q41127343-E9614E7B-C289-4739-B0B3-C60745A4057FQ41695599-689DE7E0-70F3-4129-B6CA-78F572522F2BQ41719290-DC774C42-EBE9-423D-8B70-74144F35F249Q42331361-E153D7DF-BA30-4FF2-9670-4E6230D52998Q42331368-182B98B6-9D04-485F-AEB7-F986EF6BF8F6Q42364056-E0C5500A-7844-4F9E-978A-4F751CFD90A5Q42712906-3922E722-BC0E-46BB-92F1-6D1268A006C8Q42797318-6BC18E2D-5CAA-4575-8F79-8286E2EDBEAEQ43079684-7CF1BDEC-7B00-4F6B-9232-3DF653D6E7FAQ44204175-06D600B6-6AB3-454B-8522-E59C542E7C63Q50048193-C7C3BBCE-D7FC-436A-968E-CF9DE3CDD1BDQ51225225-F99FB8B0-E9BC-4196-8959-DE64B69CD066Q51795779-08A1C452-8C25-42F6-92F0-108D503A4EB0Q53741787-AEFD07A4-9DE9-4CB9-832B-36CB1F523F64Q53775540-02113DCB-93F7-431A-AA86-3E20A9C7C2BEQ53794639-91747011-E156-480C-8057-3C6881471895Q56839497-177F2FAF-1913-497F-820E-70EBB6AF2216Q56839498-CF5D2D30-3BE6-4F0A-9384-053CC7EB84DA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabrice Compain
@ast
Fabrice Compain
@en
Fabrice Compain
@es
Fabrice Compain
@nl
Fabrice Compain
@sl
type
label
Fabrice Compain
@ast
Fabrice Compain
@en
Fabrice Compain
@es
Fabrice Compain
@nl
Fabrice Compain
@sl
prefLabel
Fabrice Compain
@ast
Fabrice Compain
@en
Fabrice Compain
@es
Fabrice Compain
@nl
Fabrice Compain
@sl
P106
P31
P496
0000-0003-0091-3881